Table 4.
A1M Outcome Table
Reference | Population | Dose | Blood pressure (mmHg) | Proteinuria | |||
---|---|---|---|---|---|---|---|
A1M | Control | A1M | Control | A1M | Control | ||
Erlandsson, 2014 [29] | STOX1 transgene mouse model (n = NR) | A1M injections from DG6 | Placebo, buffer solution | Unknown. States that A1M significantly reduced hypertension throughout pregnancy. | N/A | Unknown. States that A1M significantly reduced proteinuria throughout pregnancy. | N/A |
Naav, 2015 [30] | Rabbits infused with 20 mg/kg of HbF (n = 19) | 6 mg/kg of A1M | Nothing | HbF didn’t increase BP | 11 μg/mL of albumin* | 57 μg/mL of albumin | |
Wester-Rosenlof, 2014 [11] | Ewes starved for 36 h (n = 11) | 2 bolus doses of 1.8 mg A1M/kg body weight 2 h apart | 2 separate 50 mL doses of buffer solution | MAP 36 h post treatment: 58.5* | MAP 36 h post treatment: 73.5 |
RED: Approximate value obtained by graph extrapolation
MAP mean arterial pressure, DG day of gestation, BP blood pressure
*statistically significant at p < 0.05